# Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma

> **NCT01884428** · PHASE1 · UNKNOWN · sponsor: **Armando Santoro, MD** · enrollment: 24 (estimated)

## Conditions studied

- Hodgkin's Lymphoma

## Interventions

- **DRUG:** panobinostat
- **DRUG:** Ifosfamide
- **DRUG:** Gemcitabine
- **DRUG:** Vinorelbine
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT01884428
- **Lead sponsor:** Armando Santoro, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2014-03
- **Final completion:** 2015-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01884428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01884428, "Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01884428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*